These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24499829)

  • 1. A simple tumor load-based nomogram for surgery in patients with colorectal liver and peritoneal metastases.
    Elias D; Faron M; Goéré D; Dumont F; Honoré C; Boige V; Malka D; Ducreux M
    Ann Surg Oncol; 2014 Jun; 21(6):2052-8. PubMed ID: 24499829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic similarities and differences in optimally resected liver metastases and peritoneal metastases from colorectal cancers.
    Elias D; Faron M; Iuga BS; Honoré C; Dumont F; Bourgain JL; Dartigues P; Ducreux M; Goéré D
    Ann Surg; 2015 Jan; 261(1):157-63. PubMed ID: 24509197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Prognostic Nomogram for Patients with Peritoneally Metastasized Colorectal Cancer Treated with Cytoreductive Surgery and HIPEC.
    Simkens GA; van Oudheusden TR; Nieboer D; Steyerberg EW; Rutten HJ; Luyer MD; Nienhuijs SW; de Hingh IH
    Ann Surg Oncol; 2016 Dec; 23(13):4214-4221. PubMed ID: 27027308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneal carcinomatosis with synchronous liver metastases from colorectal cancer: Who will benefit from complete cytoreductive surgery?
    Delhorme JB; Dupont-Kazma L; Addeo P; Lefebvre F; Triki E; Romain B; Meyer N; Bachellier P; Rohr S; Brigand C
    Int J Surg; 2016 Jan; 25():98-105. PubMed ID: 26607853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should patients with peritoneal carcinomatosis of colorectal origin with synchronous liver metastases be treated with a curative intent? A case-control study.
    Maggiori L; Goéré D; Viana B; Tzanis D; Dumont F; Honoré C; Eveno C; Elias D
    Ann Surg; 2013 Jul; 258(1):116-21. PubMed ID: 23207243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritoneal carcinomatosis and liver metastases from colorectal cancer treated with cytoreductive surgery perioperative intraperitoneal chemotherapy and liver resection.
    Chua TC; Yan TD; Zhao J; Morris DL
    Eur J Surg Oncol; 2009 Dec; 35(12):1299-305. PubMed ID: 19632081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synchronous liver resection with cytoreductive surgery for the treatment of liver and peritoneal metastases from colon cancer: results from an Australian centre.
    Alzahrani N; Ung L; Valle SJ; Liauw W; Morris DL
    ANZ J Surg; 2017 Nov; 87(11):E167-E172. PubMed ID: 26178318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological factors and long-term outcome comparing between lung and peritoneal metastasectomy after hepatectomy for hepatocellular carcinoma in a tertiary institution.
    Kow AW; Kwon CH; Song S; Kim JM; Joh JW
    Surgery; 2015 Apr; 157(4):645-53. PubMed ID: 25794626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nomogram for prediction of prognosis in patients with initially unresectable colorectal liver metastases.
    Imai K; Allard MA; Castro Benitez C; Vibert E; Sa Cunha A; Cherqui D; Castaing D; Bismuth H; Baba H; Adam R
    Br J Surg; 2016 Apr; 103(5):590-9. PubMed ID: 26780341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of visible cardiophrenic angle lymph nodes in the presence of peritoneal metastases from colorectal cancers.
    Elias D; Borget I; Farron M; Dromain C; Ducreux M; Goéré D; Honoré C; Boige V; Dumont F; Malka D; Pottier E; Caramella C
    Eur J Surg Oncol; 2013 Nov; 39(11):1214-8. PubMed ID: 24044805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery.
    Beppu T; Sakamoto Y; Hasegawa K; Honda G; Tanaka K; Kotera Y; Nitta H; Yoshidome H; Hatano E; Ueno M; Takamura H; Baba H; Kosuge T; Kokudo N; Takahashi K; Endo I; Wakabayashi G; Miyazaki M; Uemoto S; Ohta T; Kikuchi K; Yamaue H; Yamamoto M; Takada T
    J Hepatobiliary Pancreat Sci; 2012 Jan; 19(1):72-84. PubMed ID: 22020927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of patients with colorectal liver metastasis: analysis of 1,613 consecutive cases.
    Dexiang Z; Li R; Ye W; Haifu W; Yunshi Z; Qinghai Y; Shenyong Z; Bo X; Li L; Xiangou P; Haohao L; Lechi Y; Tianshu L; Jia F; Xinyu Q; Jianmin X
    Ann Surg Oncol; 2012 Sep; 19(9):2860-8. PubMed ID: 22526903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escalation of socioeconomic disparities among patients with colorectal cancer receiving advanced surgical treatment.
    Tabrizian P; Overbey J; Carrasco-Avino G; Bagiella E; Labow DM; Sarpel U
    Ann Surg Oncol; 2015 May; 22(5):1746-50. PubMed ID: 25388060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with peritoneal hepatocellular carcinoma.
    Tabrizian P; Franssen B; Jibara G; Sweeney R; Sarpel U; Schwartz M; Labow D
    J Surg Oncol; 2014 Dec; 110(7):786-90. PubMed ID: 25091997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is unexpected peritoneal carcinomatosis still a contraindication for resection of colorectal liver metastases? Combined resection of colorectal liver metastases with peritoneal deposits discovered intra-operatively.
    Allard MA; Adam R; Ruiz A; Vibert E; Paule B; Levi F; Sebagh M; Guettier C; Azoulay D; Castaing D
    Eur J Surg Oncol; 2013 Sep; 39(9):981-7. PubMed ID: 23845705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer.
    Elias D; Benizri E; Pocard M; Ducreux M; Boige V; Lasser P
    Eur J Surg Oncol; 2006 Aug; 32(6):632-6. PubMed ID: 16621428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIPEC + EPIC versus HIPEC-alone: differences in major complications following cytoreduction surgery for peritoneal malignancy.
    McConnell YJ; Mack LA; Francis WP; Ho T; Temple WJ
    J Surg Oncol; 2013 May; 107(6):591-6. PubMed ID: 23129533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy treatment of colorectal peritoneal metastases: cohort analysis of high volume disease and cure rate.
    Cashin PH; Dranichnikov F; Mahteme H
    J Surg Oncol; 2014 Aug; 110(2):203-6. PubMed ID: 24846340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and HIPEC: preliminary results in highly selected patients.
    Robella M; Vaira M; Marsanic P; Mellano A; Cinquegrana A; Sottile A; De Simone M
    Minerva Chir; 2013 Dec; 68(6):551-8. PubMed ID: 24193287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of ovarian metastases of colorectal and appendiceal carcinoma in the era of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Kuijpers AM; Mehta AM; Aalbers AG; van Driel WJ; Boot H; Verwaal VJ
    Eur J Surg Oncol; 2014 Aug; 40(8):937-42. PubMed ID: 24630923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.